[ Price : $8.95]
TNS Media Intelligence says that drug company ad spending has been essentially flat in the first nine months of this year compared...[ Price : $8.95]
The Obama Administration lays out deadlines for agencies to improve their open government activities.[ Price : $8.95]
New research calls into question a recent FDA-ordered warning about an increased risk of suicidal thoughts and actions associated ...[ Price : $8.95]
Nutra Pharma says it will launch OTC and Rx versions of its pain reliever Nyloxin.[ Price : $8.95]
Cubist Pharmaceuticals closes enrollment in its CB-500,929 (ecallantide) Phase 2 program, an investigational therapy for reducing ...[ Price : $8.95]
FDA approves two Tris Pharma NDAs for once-daily clonidine extended-release suspension and tablets to treat hypertension.[ Price : $8.95]
Members of FDAs Cardiovascular and Renal Drugs Advisory Committee say that Novartis Certican appears to be safe and effective in p...[ Price : $8.95]
Consulting editor John Scharmann reviews the history of FDAs regional offices and asks whether they have a value-added function.